우리나라 백신의 수출경쟁력 분석

• 영문명: A Study on Vaccine Export Competitiveness of Korea: Focusing on Market Share, Trade Specialization Index and Revealed Comparative Advantage
• 발행기관: 한국보건사회약료경영학회
• 저자명: 고원정(Won-Jeong Ko) 이상원(Sang-Won Lee)
• 간행물 정보: 『한국보건사회약료경영학회지』제9권 제2호, 121~130쪽, 전체 10쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2021.11.30

영문 초록

Abstract—OBJECTIVES This study aims to analyze the vaccine export competitiveness of Korea by comparing 19 countries. METHODS We used the import and export data of 20 countries including Korea, extracted from TradeMap database. Using the data, 3 trade indexes: Market Share, TSI(Trade Specialization Index), and RCA(Revealed Comparative Advantage) are calculated. The period of the analysis is 10 years, but data of 10 years are too big to handle. So, this study just focus on 3 points of the years: 2010, 2015, 2020. RESULTS Korea s vaccine market share is less than 1%, and specializing in imports rather than exports. Korea vaccine also has a comparative inferiority in vaccine exports compared to other countries. CONCLUSIONS Considering the 3 trade indexes together, vaccine export competitiveness of Korea is low. Various strategies are needed to increase the export competitiveness.

목차

서론

연구방법

연구결과

고찰 및 결론

감사의 말씀

키워드

vaccine export export competitiveness